NanoMosaic Announces its “Proteomics/Multi-Omics Early Access Program” and its First System Sale to a Prestigious Boston Hospital
- Wednesday, February 2, 2022, 7:18
- Business
- Add a comment
BOSTON, Feb. 2, 2022 /PRNewswire/ — NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications, has announced that it has officially opened its “Proteomics/Multi-Omics Early…
About the Author
adminasapcorp has written 41525 stories on this site.